The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...

Singulair was a blockbuster product for Merck after its launch in 1998, offering relief in a pill as an alternative to an ...

His medication list included albuterol, budesonide-formoterol inhaler, fluticasone nasal spray, montelukast, tiotropium bromide inhaler, and loratadine daily." ...